For medical professionals, the decision to invest in new technology isn’t just about clinical innovation; it’s about timing. With the expanded 2025 Section 179 deduction, that timing couldn’t be better.
Under Federal Bill H.R. 1, Section 179 has been significantly enhanced. Not only has the deduction limit doubled to $2.5 million, but the phase-out threshold has also increased to $4 million, and 100% bonus depreciation has been reinstated. This tax code establishes the most advantageous program in recent history for investing in medical equipment for your practice.
Whether you’re considering investing in a Radial Pressure Wave, Focused Shockwave, or EMTT device, Section 179 enables you to deduct the full purchase price of qualifying equipment in the same year it’s acquired.
The result?
- Immediate savings
- Accelerated ROI
- Improved patient care
What Is Section 179 and Why It Matters to Medical Professionals
Section 179 of the IRS tax code is a government incentive that encourages businesses to invest in themselves by purchasing advanced capital equipment, including medical equipment or technology that advances patient care and facilitates practice growth. Instead of depreciating the asset over several years, you can deduct 100% of the cost in the year it’s put into use.
This incentive applies to newly purchased equipment, even if it is financed, as long as the devices are placed in service before the end of the year (by December 31, 2025).
For healthcare providers, this means modernizing your continuum of care with less financial strain. The ability to fully expense investments from the outset, which allows you to focus on what matters most, delivering optimal outcomes for patients.
Section 179 for 2025: What’s New This Year
With the immediate financial impact and tax advantages of the updated Section 179 parameters, medical practices have a unique opportunity to leverage generous financial benefits, making this the most powerful year yet to take advantage of the Section 179 deduction. This exceptional tax allowance means you can upgrade, expand, and improve your practice while maximizing financial savings on essential purchases.
Here’s what’s changed under the new legislation:
- Deduction limit doubled to $2.5 million
- Phase-out threshold raised to $4 million
- 100% bonus depreciation reinstated
ROI Example:
|
Potential Tax Savings Medical Device: $50,000 Deduction: $50,000 Tax savings: (assuming 35% tax bracket) $17,500 Cost of Equipment After Tax Savings: $32,500 |
Consult your tax advisor for eligibility.
Who Qualifies for the Section 179
Deduction
Section 179 applies to most business entities, including medical practices and clinics, whether they are sole proprietors, partnerships, or corporations, as long as the qualifying assets are used for business purposes more than 50% of the time.
You can take advantage of the deduction whether you purchase or finance your equipment. Capital Equipment Finance Agreements qualify, allowing you to make minimal payments in 2025 while still writing off up to $2.5 million of the purchase price.
For independent physicians, group practices, or extensive healthcare facilities, Section 179 levels the playing field, stimulating growth potential through wise, strategic investment.
How Section 179 Accelerates ROI and Practice Growth
Section 179 does more than reduce your tax burden; it enables you to scale. By freeing up cash flow, you can reinvest those savings into other areas of your practice, such as:
- Staff training on new technologies
- Marketing and patient education
- Facility upgrades and patient experience enhancements
When paired with CuraMedix technologies, Section 179 becomes a pathway to financial savings and an unmatched opportunity to bring patient care to new heights.
EPAT and ESWT enable clinicians to treat musculoskeletal pain, tendinopathies, and soft tissue conditions non-invasively, while EMTT expands regenerative possibilities for chronic pain and mobility issues. All of these devices are highly complementary, and it’s an ideal time to consider the full suite of devices.
CuraMedix Advantage:
- Advanced regenerative technologies from STORZ Medical, the gold standard in Shockwave and EMTT
- Comprehensive training and marketing support
- Proven track record of physician success across specialties
In other words, Section 179 helps you save now, and CuraMedix partners with practices to help you deliver better results long-term.
Section 179 in Action: Real Numbers, Real Impact
Let’s put the numbers into perspective.
If your medical practice invests $100,000 in new medical devices from CuraMedix, your potential tax savings could reach $35,000, assuming a 35% tax rate. Your actual after-tax investment? Just $65,000, while gaining the ability to deliver cutting-edge, evidence-based regenerative care.
These impressive savings directly impact your bottom line and set your practice apart in an increasingly competitive medical landscape.
Why Act Now — The Year-End Deadline Matters
To qualify for the 2025 deduction, your equipment must be purchased and placed in service by December 31, 2025.
This means that delivery, installation, setup, and clinical readiness must be completed by the end of the year.
Financed equipment also qualifies, allowing you to preserve working capital while still reaping the benefits of the full deduction. The earlier you act, the more control you have over scheduling, delivery, and implementation.
Take Advantage of Section 179 with CuraMedix
2025 presents an unmatched opportunity to invest in your practice, save significantly on taxes, and elevate patient care through evidence-based regenerative technologies.
With CuraMedix, you gain more than world-class technology powered by STORZ Medical; you gain a trusted partner dedicated to your long-term success. From Shockwave (EPAT and ESWT) to EMTT, our portfolio is designed to advance healing and deliver optimal outcomes.
Ready to maximize your 2025 Section 179 savings?
Contact CuraMedix today to explore how you can leverage Section 179 to invest in the future of your practice and your patients.
Disclaimer
This information is provided for educational purposes only and does not constitute tax advice. Please consult your tax advisor to determine eligibility for Section 179 deductions based on your unique financial situation.
About CuraMedix
CuraMedix, the leading U.S. distributor of STORZ Medical devices, provides its partners with exceptional customer service, marketing guidance, and technical support. The CuraMedix portfolio of products includes the radial pressure wave and focused shockwave devices, and now MAGNETOLITH, the new EMTT device.
